Cite

HARVARD Citation

    Fabbri, M. et al. (2020). Levodopa/Carbidopa Intestinal Gel Long‐Term Outcome in Parkinson's Disease: Focus on Dyskinesia. Movement disorders clinical practice. 7 (8), pp. 930-939. [Online]. 
  
Back to record